William S. Gilmer, MD, is affiliated with Edward Hines Jr VA Hospital and Northwestern University Feinberg School of Medicine. His publications from 2006 to 2024 focus on depression, including major depressive disorder and bipolar disorder. His work covers clinical outcomes of intravenous ketamine treatment, quantitative electroencephalogram biomarkers for predicting remission in major depression, the impact of episode duration on treatment outcomes, and the use of divalproex in acute bipolar depression. He has also contributed to research on the intersection of HIV and depression in primary care.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
